You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博拓生物(688767.SH):2024年度淨利潤1.77億元 同比增長65.74%
格隆匯 02-26 16:17

格隆匯2月26日丨博拓生物(688767.SH)公佈2024年度業績快報,報告期內,公司實現營業總收入5.61億元,較上年同期增長26.80%;實現歸屬於母公司所有者的淨利潤1.77億元,較上年同期增長65.74%;實現歸屬於母公司所有者的扣除非經常性損益的淨利潤1.27億元,較上年同期增長59.35%。

報告期內,公司持續深耕POCT體外診斷細分行業,有效把握客戶需求,積極拓展國際國內市場,實現銷售收入穩步增長;多措並舉提升管理及生產運營效率,有效達成全年降本增效目標,促進業績增長。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account